Unregistered Sales of Equity Securities and Use of Proceeds.
−Removed: Unregistered Sales of Equity Securities for the Three Months Ended March 31, 2022
−Removed: There were no unregistered sales of equity securities during the three months ended March 31, 2022.
+Added: Unregistered Sales of Equity Securities for the Three Months Ended June 30, 2022
+Added: There were no unregistered sales of equity securities during the three months ended June 30, 2022.
Use of Proceeds from our IPO
9 unchanged sentences
Description of Common Stock (incorporated by reference to Exhibit 4.1 to the Form 10-K filed by the Registrant on March 21, 2022)
−Removed: Office/Laboratory Lease between the Registrant and 7 th Street Property III General Partnership, having a commencement date of January 13, 2022 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed by the Registrant with the SEC on January 19, 2022)
−Removed: Rider 1 to Office/Laboratory Lease between the Registrant and 7 th Street Property III General Partnership, effective as of the lease commencement date of January 13, 2022 (incorporated by reference to Exhibit 10.29 to the Form 10-K filed by the Registrant with the SEC on March 21, 2022)
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
Caribou Biosciences, Inc.
+Added: August 9 , 2022
/s/ Rachel E.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 9, 2022
O’Byrne
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.